Signal over Noise: Playing offense and defense through healthcare
From UBS On-Air: Market Moves by Client Strategy Office
June 7, 2026 · 6 min
About this episode
This episode discusses the evolving role of healthcare in investment portfolios, highlighting innovation in the pharma sector and the impact of AI and genomics.
Health care has not seen the same stock market traction as AI and power and resources over the past year, but continues to serve as a key ingredient to a diversified portfolio and a source of stability. This episode explores how the sector is not just a defensive play, with the pharma industry moving toward innovation-driven growth led by GLP-1 drugs. At the same time, advances in artificial intelligence and genomics are transforming how drugs are discovered, while an aging global population provides a powerful structural tailwind for demand.
Topics covered
- healthcare
- investment strategies
- pharmaceutical innovation
- artificial intelligence
- aging population
- diversified portfolio
Keywords
- healthcare
- investment
- pharmaceuticals
- AI
- genomics
- GLP-1
- aging population
Mentioned in this episode
Organizations: pharma industry, health care, artificial intelligence, genomics
Products: GLP-1 drugs
Places: global population
More episodes of UBS On-Air: Market Moves
- Washington Weekly Podcast: US-Iran, US trade policy, FISA, & Secure America Act · June 12, 2026 · 16 min
- UBS On-Air: Paul Donovan Daily Audio 'Carrying on, without keeping calm' · June 12, 2026 · 2 min
- UBS On-Air: Paul Donovan Daily Audio 'How bad is the ECB error?' · June 11, 2026 · 3 min
- Viewpoints with Burkhard Varnholt - A global markets podcast (Ep. 65) · June 10, 2026 · 6 min
- UBS On-Air: Paul Donovan Daily Audio 'Inflation bonanza' · June 10, 2026 · 3 min
- House Call: Talking Equity Markets with UBS Asset Management · June 9, 2026 · 19 min
Explore listener stats, chart rankings, contacts and more on the UBS On-Air: Market Moves podcast page.